Picture of HLS Therapeutics logo

HLS HLS Therapeutics News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareBalancedSmall CapNeutral

Brief: Hls Therapeutics Reports Qtrly Loss Per Share $0.15

May 6 (Reuters) - HLS Therapeutics Inc  HLS.TO :
    * HLS THERAPEUTICS ANNOUNCES FIRST QUARTER FISCAL 2021
FINANCIAL
RESULTS
    * HLS THERAPEUTICS INC - QTRLY Q1 2021 REVENUE OF $14.3
MILLION
    * HLS THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.15

Source text for Eikon:  ID:nCNWXXCNHa 
Further company coverage:  HLS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on HLS Therapeutics

See all news